4.7 Article

SARS-CoV-2 Omicron variant shows less efficient replication and fusion activity when compared with Delta variant in TMPRSS2-expressed cells

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Multidisciplinary Sciences

Enhanced fusogenicity and pathogenicity of SARS-CoV-2 Delta P681R mutation

Akatsuki Saito et al.

Summary: During the COVID-19 pandemic, the B.1.617.2/Delta variant has been found to be highly fusogenic and more pathogenic in infected hamsters compared to prototypic SARS-CoV-2. The P681R mutation in the spike protein of this variant enhances viral fusogenicity and pathogenicity.

NATURE (2022)

Review Cell Biology

Mechanisms of SARS-CoV-2 entry into cells

Cody B. Jackson et al.

Summary: The entry of SARS-CoV-2 into host cells is facilitated by the interaction between the viral spike protein and ACE2, leading to virus-cell membrane fusion, which has been extensively studied at the structural and cellular levels worldwide. This understanding has paved the way for the development of effective vaccines in response to the COVID-19 pandemic, caused by the infection with SARS-CoV-2.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2022)

Article Immunology

Impact of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variant-Associated Receptor Binding Domain (RBD) Mutations on the Susceptibility to Serum Antibodies Elicited by Coronavirus Disease 2019 (COVID-19) Infection or Vaccination

Lin-Lei Chen et al.

Summary: SARS-CoV-2 variants P.3 and B.1.617.1 can evade neutralizing response from convalescent serum and vaccine-induced serum. The E484K mutation in the spike protein has the greatest impact on receptor binding domain binding.

CLINICAL INFECTIOUS DISEASES (2022)

Article Immunology

Coronavirus Disease 2019 (COVID-19) Re-infection by a Phylogenetically Distinct Severe Acute Respiratory Syndrome Coronavirus 2 Strain Confirmed by Whole Genome Sequencing

Kelvin Kai-Wang To et al.

Summary: The study confirmed reinfection in an apparently immunocompetent patient 142 days after the first symptomatic episode, rather than persistent viral shedding. This suggests that SARS-CoV-2 may continue to circulate among humans, even with natural herd immunity, highlighting the need for further research on protective immunological correlates for vaccine design.

CLINICAL INFECTIOUS DISEASES (2021)

Article Biology

Low dose inocula of SARS-CoV-2 Alpha variant transmits more efficiently than earlier variants in hamsters

Bobo Wing-Yee Mok et al.

Summary: The study found that the Alpha variant of SARS-CoV-2 has increased competitive fitness in a hamster model, replicating and shedding more efficiently in the nasal cavity, which may contribute to its rapid transmission. These results help explain why emerging variants of the virus are more efficient in spreading.

COMMUNICATIONS BIOLOGY (2021)

Article Multidisciplinary Sciences

Host and viral determinants for efficient SARS-CoV-2 infection of the human lung

Hin Chu et al.

Summary: Understanding the factors contributing to efficient SARS-CoV-2 infection in human cells can provide insights into the virus's transmissibility and pathogenesis. The study identifies heparan sulfate as an important attachment factor, while sialic acids on ACE2 may restrict efficient spike/ACE2 interaction in lung tissues. Moreover, the presence of a furin-like cleavage site in SARS-CoV-2 spike is crucial for efficient virus replication in human lungs.

NATURE COMMUNICATIONS (2021)

Article Biochemistry & Molecular Biology

Soluble ACE2-mediated cell entry of SARS-CoV-2 via interaction with proteins related to the renin-angiotensin system

Man Lung Yeung et al.

Summary: Research has identified the crucial role of human host factors and sACE2 protein in virus dependency factors, cell entry, and other aspects of SARS-CoV-2 infection, shedding light on the pathogenesis of COVID-19 and potential treatment strategies.
Editorial Material Medicine, General & Internal

Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic

Salim S. Abdool Karim et al.

LANCET (2021)

Article Multidisciplinary Sciences

Membrane fusion and immune evasion by the spike protein of SARS-CoV-2 Delta variant

Jun Zhang et al.

Summary: The Delta variant of SARS-CoV-2 is more efficient at fusing membranes at low levels of cellular receptor ACE2, possibly contributing to its heightened transmissibility. Each variant shows different rearrangement of the antigenic surface of the S protein, but only the changes in the RBD make it a better target for therapeutic antibodies.

SCIENCE (2021)

Article Multidisciplinary Sciences

Cross-linking peptide and repurposed drugs inhibit both entry pathways of SARS-CoV-2

Hanjun Zhao et al.

Summary: This study identifies a dual-functional cross-linking peptide 8P9R that can inhibit SARS-CoV-2 entry pathways in cells and suppress viral replication in animal models. The combination therapy of drugs like arbidol, chloroquine, and camostat shows promising results in inhibiting SARS-CoV-2 replication, suggesting a potential treatment strategy for COVID-19.

NATURE COMMUNICATIONS (2021)

Article Cell Biology

B.1.617.2 enters and fuses lung cells with increased efficiency and evades antibodies induced by infection and vaccination

Prerna Arora et al.

Summary: The Delta variant, B.1.617.2, has spread to over 80 countries, showing evasion of antibodies, resistance to certain therapies, and enhanced transmissibility.

CELL REPORTS (2021)

Article Microbiology

TMPRSS2 promotes SARS-CoV-2 evasion from NCOA7-mediated restriction

Hataf Khan et al.

Summary: The IFN-inducible short isoform of human nuclear receptor coactivator 7 (NCOA7) inhibits virus entry by promoting endo-lysosomal vesicle acidification, and is effective against SARS-CoV-2 and other coronaviruses. The acquisition of furin cleavage may have favored the utilization of cell surface TMPRSS proteases as a strategy to evade the suppressive effects of IFN-induced endo-lysosomal dysregulation on virus infection.

PLOS PATHOGENS (2021)

Article Medicine, General & Internal

Emerging SARS-CoV-2 variants expand species tropism to murines

Huiping Shuai et al.

Summary: The study found that the SARS-CoV-2 variant B.1.1.7 and other N501Y-carrying variants can infect wildtype mice and rats, producing high viral loads and infectious virus particles in their respiratory tract. This suggests that these variants may have evolved to expand species tropism to murines.

EBIOMEDICINE (2021)

Article Multidisciplinary Sciences

Drugs that inhibit TMEM16 proteins block SARS-CoV-2 spike-induced syncytia

Luca Braga et al.

Summary: COVID-19 patients' lungs contain infected pneumocytes with abnormal morphology and frequent multinucleation, leading to the formation of syncytia driven by the activation of the SARS-CoV-2 spike protein. The antihelminthic drug niclosamide has shown to effectively inhibit cell fusion, potentially providing a new therapeutic approach for COVID-19 disease pathogenesis.

NATURE (2021)

Article Microbiology

The furin cleavage site in the SARS-CoV-2 spike protein is required for transmission in ferrets

Thomas P. Peacock et al.

Summary: Efficient transmission of SARS-CoV-2 among infected ferrets is dependent on a functional furin cleavage site in the spike protein. The virus has a selective advantage in lung cells and primary human airway epithelial cells due to a polybasic insertion, but replication may be impaired in certain cell lines.

NATURE MICROBIOLOGY (2021)

Article Multidisciplinary Sciences

Lectins enhance SARS-CoV-2 infection and influence neutralizing antibodies

Florian A. Lempp et al.

Summary: The study reveals that C-type lectin receptors and other factors can serve as attachment receptors for SARS-CoV-2 infection, enhancing ACE2-mediated infection and modulating the neutralizing activity of antibodies.

NATURE (2021)

Article Medicine, General & Internal

The impact of spike N501Y mutation on neutralizing activity and RBD binding of SARS-CoV-2 convalescent serum

Lu Lu et al.

Summary: The study demonstrates that the N501Y mutation has a significant impact on neutralizing activity of COVID-19 convalescent sera and anti-RBD IgG assays. Patients infected with N501Y variants may exhibit reduced antibody binding and lower positivity rates in IgG assays.

EBIOMEDICINE (2021)

Article Biochemistry & Molecular Biology

SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes

Waradon Sungnak et al.

NATURE MEDICINE (2020)

Article Multidisciplinary Sciences

Chloroquine does not inhibit infection of human lung cells with SARS-CoV-2

Markus Hoffmann et al.

NATURE (2020)